Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placenta-derived mesenchymal stem cells for nail bed injury repair
IRCT20240215061014N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of placenta-derived mesenchymal stem cells in nail bed injury, sponsored by Tehran University of Medical Sciences. Primary endpoints: Zook Criteria Score and Wong-Baker FACES Criteria Score. Started Apr 2025; status: completed.
02
Drugs
placenta-derived mesenchymal stem cells
03
Conditions
nail bed injury
Beyond the preview
Go deeper on IRCT20240215061014N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240215061014N1.